4.4 Article

Effects of trypanocidal drugs on DNA synthesis: new insights into melarsoprol growth inhibition

期刊

PARASITOLOGY
卷 148, 期 10, 页码 1143-1150

出版社

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0031182021000317

关键词

Antitrypanosomal drugs; cell cycle; DNA synthesis; fexinidazole; gamma-glutamylcysteine synthetase; melarsoprol; ribonucleotide reductase; T. brucei; Trypanosomatids; trypanothione

资金

  1. NIAID NIH HHS [R21 AI113419] Funding Source: Medline

向作者/读者索取更多资源

Trypanothione serves as the primary thiol redox carrier in Trypanosomatids, with melarsoprol directly inhibiting its function to suppress DNA synthesis, while other drugs have more subtle effects. These findings suggest that DNA synthesis may be a promising therapeutic target in the development of antitrypanosomal drugs.
Trypanothione is the primary thiol redox carrier in Trypanosomatids whose biosynthesis and utilization pathways contain unique enzymes that include suitable drug targets against the human parasites in this family. Overexpression of the rate-limiting enzyme, gamma-glutamylcysteine synthetase (GSH1), can increase the intracellular concentration of trypanothione. Melarsoprol directly inhibits trypanothione and has predicted the effects on downstream redox biology, including ROS management and dNTP synthesis that require further investigation. Thus, we hypothesized that melarsoprol treatment would inhibit DNA synthesis, which was tested using BrdU incorporation assays and cell cycle analyses. In addition, we analysed the effects of eflornithine, which interfaces with the trypanothione pathway, fexinidazole, because of the predicted effects on DNA synthesis, and pentamidine as an experimental control. We found that melarsoprol treatment resulted in a cell cycle stall and a complete inhibition of DNA synthesis within 24 h, which were alleviated by GSH1 overexpression. In contrast, the other drugs analysed had more subtle effects on DNA synthesis that were not significantly altered by GSH1 expression. Together these findings implicate DNA synthesis as a therapeutic target that warrants further investigation in the development of antitrypanosomal drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据